Neurobiology and Physiology of the Endocannabinoid System

Herausgeber: Patel, Vinood B; R Martin, Colin; Preedy, Victor R

• Gebundenes Buch

Produktbeschreibung

Neurobiology and Physiology of the Endocannabinoid System offers readers a comprehensive reference on the neurobiology of this system and the use of cannabimimetic compounds to induce neurological changes and confer symptom relief. With sections on both natural and synthetic compounds, the book's broad coverage allows readers to learn about their use with multiple conditions, as well as the working biology of the endocannabinoid system, its receptors and its ligands. This volume provides a platform for research on the effects of this system and its modulation in brain function and neurological dysfunction.

Produktdetails

• Verlag: Elsevier Science
• Seitenzahl: 600
• Erscheinungstermin: 5. Juli 2023
• Englisch
• Abmessung: 224mm x 284mm x 39mm
• Gewicht: 1900g
• ISBN-13: 9780323908771
• ISBN-10: 0323908772
• Artikelnr.: 67292858

Inhaltsangabe

Preface
I. Setting the scene and introductory chapters
1. Distribution of the endocannabinoid system: linking signalling and
development Michaela Dvorakova and Anna Kalinovsky
2. The endocannabinoid system, immunomodulation, and LPS-induced
inflammation Elliot Lloyd, Nina Nguyen and Judith Hellman
3. Physiology of the endocannabinoid systems: imaging and the use of
positron emission tomography (PET) Claudia Poluga, Cassis Varlow, Neil
Vasdev, Isabelle Boileau and Laura M. Best
4. The endocannabinoid system and aging Prof. Vahid Reza Askari
5. The endocannabinoid system and post traumatic stress disorder (PTSD): a
new narrative Luke Ney, Kevin M. Crombie and Leah M. Mayo
II. Neurobiology of the endocannabinoid system
6. The protective effect of the endocannabinoid system in neurotoxin
induced damage to hippocampal neurons: a focus on light and electron
microscopy Rita Yakovlevna Gordon, Valentina Kitchigina and Irina Mikheeva
7. Endocannabinoid Signaling and excitatory and inhibitory synapses Jian
Liang and Corette J. Wierenga
8. The endocannabinoids and potassium channels: an updated narrative
Yu-Fung Lin
9. Social interactions and neural activity: linking cellular studies and
endocannabinoid signalling Cheryl McCormick
10. Exercise and Parkinson's disease: linking in the cannabinoid type 1
(CB1) and type 2 (CB2), and mu-opioid receptors Marucia Chacur Sr.,
Caroline Cristiano Real Gregório and Karina Henrique Binda
11. Endocannabinoids and inhalant misuse: neuropsychological aspects John
Woodward
12. Fatty acid amide hydrolase (FAAH) in substance use disorders: FAAH
regulation and inhibition in cannabis, alcohol, nicotine, stimulant, and
opioid use disorders Garth E. Terry and Greta Niemela
13. Treatment of pain with dual fatty acid amide hydrolase (FAAH) enzyme
and human soluble epoxide hydrolase (sEH) enzyme inhibitors: interlinking
the endocannabinoid system Stevan Pecic and Ram Kandasamy
14. WWL70: linking the hydrolyses 2-arachidonoylglycerol, endocannabinoid
and eicosanoid pathways: therapeutic potential and neurological disease
Mikiei Tanaka and Yumin Zhang
15. Endocannabinoid catabolic enzyme inhibitors and pain alleviation Sidney
Stevens Negus and Clare Diester
16. The endocannabinoid system in health and disease: features in epilepsy
Christopher Martínez-Aguirre, Maria de los Angeles Nuñez-Lumbreras and
Luisa Lilia Rocha
17. The endocannabinoid system and autoimmune demyelination: a focus on
multiple sclerosis Ana Bernal-Chico, Andres Baraibar, Alvaro Moreno-Garcia,
Teresa Colomer, Ester Sanchez, Carmen Utrilla, Carlos Matute and Susana
Mato
18. Endocannabinoid signaling and the lateral habenula Jiang-Hong Ye
19. On the interplay among endocannabinoid, noradrenergic and
glucocorticoid systems: evidence from aversive memory studies Moisés Dos
Santos Corrêa, Raquel Fornari, Cristina A. Stern, Leandro José Bertoglio
and Lucas Gazarini
III. Receptor biology and responses
20. Adenosine A2A-cannabinoid CB1 receptor heteromers in the brain: From
trans-inhibition to trans-activation Ester Aso and Francisco Ciruela
21. Hippocampal CB1, CB2 receptors, the endocannabinoid system and fear
memory Ana Maria Raymundi and Cristina A. Stern
22. Beta-caryophyllene, the CB2 cannabinoid receptor-specific agonists and
wound healing Prof. S. Koyama and Thomas Heinbockel
23. The nigrostriatal dopaminergic pathway: impact of WIN 55212-2 as a
potent cannaboinoid receptor agonist Enzo Perez-Valenzuela and Jose Antonio
Fuentealba Evans
24. Peripheral cannabinoid receptor 1 antagonists and impact on adipocytes
Morvarid Kabir
25. Endocannabinoid system receptors in plasma membranes : extraction,
lipid rafts and the cortex Changiz Taghibiglou and Hajar Miranzadeh
Mahabadi
26. Applications to wound healing: cannabinoid receptor 1 antagonism and
collagen deposition Inês Correia-Sa
27. Role of the Transient Receptor Potential Vanilloid 1 (TRPV1), a
component of the endocannabinoid system, in anxiety, depression, and
cocaine addiction Carmen S. Maldonado-Vlaar and Wickensonn Norze
28. Allosteric modulators of the endocannabinoid system: Org27569 and
cannabinoid receptor 1 (CB1) Dai Lu
29. Naturally occurring DELTA-9-tetrahydrocannabinol-derivatives and
binding to CB1 and CB2 receptors: Linking in the endocannabinoid system
Irene Reyes-Resina, Rafael Rivas-Santisteban, Iu Raïch, Claudia Llinás del
Torrent, Jaume Lillo, Rafael Franco and Gemma Navarro
IV. Profiles and behaviour of selective endocannabinoids
30. New cannabinoid receptor type 1 and 2 agonists and applications to
understanding the endocannabinoid system Manuel Faundez-Parraguez
31. Fatty acid amide hydrolase, the endocannabinoid anandamide and
neurological disease Filomena Fezza
32. The endocannabinoid-system in the immuno-biology of dendritic cells
Dipyaman Ganguly
33. Palmitoylethanolamide and other anandamide congeners in
neuroinflammation-based disorders: linking in the endocannabinoid system
Enza Palazzo
34. Endocannabinoid modulation of synaptic function and behavior in the
dorsomedial hypothalamus Karen M. Crosby
35. Key role of anandamide and the endocannabinoid system in the modulation
of cardio-renal homeostasis Prof. Virna M. Martín Gimenez and Walter
Manucha
36. The endocannabinoid system: Signaling and social motivation Roberta
Monterazzo Cysneiros and Fernanda Ribeiro
V. Exogenous, synthetic other compounds linking in the endocannabinoid
system
37. Safety and toxicology of the dietary cannabinoid beta-caryophyllene
Prof. George Oliveira Sr., Bruna Silva, Ana Santos C. L. da Silva and
Luciano Silva Lopes
38. Synthetic cannabimimetics: an overview Prof. M. Kassiou
VI. Compartive studies in non neurological systems
39. Non Neurological Aspects of the Endocannabinoid System: Non Alcoholic
Fatty Liver Disease Dr. R. Ghazali
40. Components of the Endocannabinoid system: Hepatic expression levels of
the cannabinoid receptors and microRNAs Sema Bolkent and Zeynep Mine Coskun
41. Tumour growth and the endocannabinoid system: investigating CB2
agonists Josee Guindon, Isabel Castro-Piedras, Melissa McHann and Robert
Barnes
42. Linking Endocannabinoid System, Palmitoylethanolamide and Sarcopenia in
view of therapeutic outcomes Susanna Molinari, Eleonora Maretti, Renata
Battini and Eliana Leo
VII. Resources
43. Endocannabinoids and Resources Rajkumar Rajendram